Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Air Ambulances | 39 | 2024 | 92 | 12.820 |
Why?
|
Emergency Medical Services | 28 | 2024 | 1926 | 3.580 |
Why?
|
Transportation of Patients | 11 | 2013 | 175 | 1.420 |
Why?
|
Emergency Service, Hospital | 20 | 2024 | 7788 | 1.210 |
Why?
|
Wounds and Injuries | 12 | 2024 | 2474 | 1.190 |
Why?
|
Crotalus | 2 | 2018 | 7 | 1.100 |
Why?
|
Abdominal Pain | 4 | 2024 | 1064 | 1.100 |
Why?
|
Snake Bites | 2 | 2018 | 28 | 1.060 |
Why?
|
Fentanyl | 4 | 2010 | 429 | 0.970 |
Why?
|
Analgesics, Opioid | 12 | 2024 | 3759 | 0.970 |
Why?
|
Caustics | 1 | 2024 | 32 | 0.940 |
Why?
|
Rh-Hr Blood-Group System | 1 | 2024 | 65 | 0.920 |
Why?
|
Aerospace Medicine | 1 | 2024 | 95 | 0.890 |
Why?
|
Emergency Medicine | 10 | 2019 | 1195 | 0.880 |
Why?
|
Burns, Chemical | 1 | 2024 | 123 | 0.860 |
Why?
|
Hypotension | 4 | 2019 | 882 | 0.840 |
Why?
|
Injury Severity Score | 3 | 2023 | 1036 | 0.800 |
Why?
|
Acetaminophen | 4 | 2023 | 554 | 0.790 |
Why?
|
Bupropion | 2 | 2020 | 304 | 0.740 |
Why?
|
Consultants | 1 | 2021 | 53 | 0.740 |
Why?
|
Hyaluronoglucosaminidase | 2 | 2012 | 135 | 0.740 |
Why?
|
Triage | 5 | 2023 | 982 | 0.690 |
Why?
|
Diclofenac | 2 | 2019 | 67 | 0.680 |
Why?
|
Injections, Intramuscular | 3 | 2023 | 553 | 0.680 |
Why?
|
Qatar | 7 | 2024 | 40 | 0.680 |
Why?
|
Intubation, Intratracheal | 5 | 2013 | 1328 | 0.670 |
Why?
|
Craniocerebral Trauma | 1 | 2023 | 491 | 0.650 |
Why?
|
Islam | 1 | 2019 | 71 | 0.640 |
Why?
|
Aircraft | 3 | 2023 | 126 | 0.630 |
Why?
|
Blood Transfusion | 2 | 2024 | 1322 | 0.610 |
Why?
|
Tachycardia | 2 | 2020 | 603 | 0.610 |
Why?
|
Pain | 7 | 2016 | 5059 | 0.600 |
Why?
|
Blood Pressure Determination | 3 | 2008 | 641 | 0.600 |
Why?
|
Hypoglycemia | 2 | 2018 | 883 | 0.590 |
Why?
|
Antidepressive Agents, Second-Generation | 2 | 2020 | 488 | 0.580 |
Why?
|
Catheterization, Peripheral | 2 | 2012 | 343 | 0.580 |
Why?
|
Pain Measurement | 9 | 2024 | 3511 | 0.570 |
Why?
|
Blood Pressure Monitors | 2 | 2008 | 33 | 0.570 |
Why?
|
Accidents, Home | 2 | 2020 | 71 | 0.570 |
Why?
|
Disability Evaluation | 1 | 2024 | 1826 | 0.560 |
Why?
|
Blood Coagulation Disorders | 2 | 2018 | 348 | 0.550 |
Why?
|
Bibliometrics | 2 | 2019 | 351 | 0.540 |
Why?
|
Acidosis, Lactic | 1 | 2018 | 145 | 0.540 |
Why?
|
Analgesia | 3 | 2016 | 459 | 0.530 |
Why?
|
Liver Failure | 1 | 2018 | 248 | 0.510 |
Why?
|
Out-of-Hospital Cardiac Arrest | 3 | 2017 | 346 | 0.490 |
Why?
|
Evidence-Based Emergency Medicine | 1 | 2013 | 9 | 0.470 |
Why?
|
Tranexamic Acid | 1 | 2016 | 176 | 0.460 |
Why?
|
Recovery of Function | 1 | 2024 | 2979 | 0.460 |
Why?
|
Atmospheric Pressure | 1 | 2013 | 46 | 0.440 |
Why?
|
Emergency Medical Technicians | 2 | 2012 | 117 | 0.440 |
Why?
|
Musculoskeletal Diseases | 1 | 2019 | 594 | 0.430 |
Why?
|
Administration, Oral | 2 | 2019 | 4037 | 0.420 |
Why?
|
Humans | 95 | 2024 | 759098 | 0.410 |
Why?
|
Delirium | 1 | 2024 | 1653 | 0.410 |
Why?
|
Geographic Information Systems | 1 | 2014 | 280 | 0.400 |
Why?
|
Fractures, Open | 1 | 2013 | 105 | 0.400 |
Why?
|
Glipizide | 1 | 2011 | 48 | 0.390 |
Why?
|
Cardiopulmonary Resuscitation | 3 | 2017 | 1001 | 0.380 |
Why?
|
Radial Artery | 3 | 2008 | 197 | 0.380 |
Why?
|
Recombinant Proteins | 2 | 2012 | 6538 | 0.370 |
Why?
|
Etomidate | 1 | 2013 | 185 | 0.370 |
Why?
|
Glyburide | 1 | 2011 | 114 | 0.370 |
Why?
|
Glucose | 3 | 2012 | 4362 | 0.360 |
Why?
|
Endovascular Procedures | 1 | 2024 | 2136 | 0.360 |
Why?
|
Meperidine | 1 | 2010 | 38 | 0.360 |
Why?
|
Retrospective Studies | 30 | 2024 | 80125 | 0.360 |
Why?
|
Adult | 45 | 2024 | 219353 | 0.360 |
Why?
|
Propiophenones | 1 | 2010 | 28 | 0.350 |
Why?
|
Time Factors | 18 | 2024 | 40083 | 0.350 |
Why?
|
Anesthetics, Intravenous | 1 | 2013 | 398 | 0.350 |
Why?
|
Seizures | 2 | 2020 | 2908 | 0.350 |
Why?
|
Male | 55 | 2024 | 358602 | 0.350 |
Why?
|
Cerebral Hemorrhage | 3 | 2024 | 2660 | 0.340 |
Why?
|
Anticoagulants | 3 | 2016 | 4896 | 0.340 |
Why?
|
Pneumothorax | 1 | 2013 | 376 | 0.340 |
Why?
|
Female | 54 | 2024 | 390174 | 0.330 |
Why?
|
Cholecystitis | 1 | 2010 | 183 | 0.330 |
Why?
|
Middle Aged | 41 | 2024 | 219628 | 0.330 |
Why?
|
Phlebotomy | 1 | 2010 | 137 | 0.330 |
Why?
|
Homicide | 1 | 2012 | 295 | 0.320 |
Why?
|
Trauma Centers | 2 | 2012 | 934 | 0.310 |
Why?
|
Fluid Therapy | 1 | 2012 | 592 | 0.310 |
Why?
|
Oscillometry | 2 | 2005 | 145 | 0.300 |
Why?
|
Periodicals as Topic | 1 | 2019 | 1469 | 0.290 |
Why?
|
Diltiazem | 1 | 2007 | 131 | 0.280 |
Why?
|
Ketamine | 1 | 2013 | 514 | 0.280 |
Why?
|
Verapamil | 1 | 2007 | 242 | 0.280 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 4 | 2023 | 2282 | 0.270 |
Why?
|
Liver Transplantation | 1 | 2018 | 2311 | 0.260 |
Why?
|
Guideline Adherence | 3 | 2013 | 2283 | 0.260 |
Why?
|
Violence | 1 | 2012 | 927 | 0.260 |
Why?
|
Libraries, Digital | 1 | 2005 | 6 | 0.250 |
Why?
|
Poisoning | 2 | 2020 | 251 | 0.250 |
Why?
|
Intracranial Thrombosis | 1 | 2006 | 109 | 0.250 |
Why?
|
Prospective Studies | 17 | 2019 | 54190 | 0.250 |
Why?
|
Aged | 26 | 2024 | 168615 | 0.250 |
Why?
|
Efficiency, Organizational | 1 | 2009 | 694 | 0.240 |
Why?
|
Internship and Residency | 5 | 2019 | 5860 | 0.240 |
Why?
|
Ultrasonography | 4 | 2018 | 5954 | 0.230 |
Why?
|
Gallbladder Diseases | 1 | 2005 | 137 | 0.230 |
Why?
|
Calcium Channel Blockers | 1 | 2007 | 690 | 0.230 |
Why?
|
Erythroblastosis, Fetal | 1 | 2024 | 62 | 0.230 |
Why?
|
Anesthetics, Local | 1 | 2010 | 1001 | 0.210 |
Why?
|
Hypocalcemia | 1 | 2024 | 196 | 0.210 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2006 | 486 | 0.210 |
Why?
|
Stroke | 5 | 2024 | 9936 | 0.210 |
Why?
|
Physicians | 1 | 2021 | 4583 | 0.210 |
Why?
|
Law Enforcement | 1 | 2024 | 112 | 0.210 |
Why?
|
Adolescent | 16 | 2024 | 87551 | 0.210 |
Why?
|
Altitude Sickness | 1 | 2003 | 90 | 0.200 |
Why?
|
Heart Rate | 2 | 2013 | 4165 | 0.200 |
Why?
|
Hyperventilation | 1 | 2002 | 79 | 0.200 |
Why?
|
Health Services Research | 3 | 2004 | 1809 | 0.200 |
Why?
|
Child, Preschool | 11 | 2024 | 41932 | 0.200 |
Why?
|
Hospitals, Special | 1 | 2002 | 90 | 0.200 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2014 | 3193 | 0.200 |
Why?
|
Hemorrhage | 1 | 2014 | 3606 | 0.190 |
Why?
|
Ibuprofen | 1 | 2003 | 229 | 0.190 |
Why?
|
Physician Executives | 1 | 2002 | 133 | 0.190 |
Why?
|
Medication Errors | 1 | 2007 | 781 | 0.190 |
Why?
|
Endoscopy, Digestive System | 1 | 2024 | 351 | 0.190 |
Why?
|
Infusions, Subcutaneous | 2 | 2012 | 43 | 0.190 |
Why?
|
Inservice Training | 2 | 2004 | 376 | 0.190 |
Why?
|
Young Adult | 12 | 2024 | 58477 | 0.190 |
Why?
|
Urban Health Services | 1 | 2002 | 177 | 0.180 |
Why?
|
Poison Control Centers | 1 | 2020 | 76 | 0.180 |
Why?
|
Analgesics | 1 | 2007 | 1063 | 0.180 |
Why?
|
Morphine | 2 | 2016 | 656 | 0.180 |
Why?
|
Monitoring, Physiologic | 2 | 2006 | 1783 | 0.180 |
Why?
|
Observer Variation | 2 | 2018 | 2596 | 0.180 |
Why?
|
Diagnostic Errors | 2 | 2010 | 1266 | 0.180 |
Why?
|
Double-Blind Method | 6 | 2019 | 12383 | 0.180 |
Why?
|
Congresses as Topic | 2 | 2024 | 802 | 0.180 |
Why?
|
Software | 1 | 2014 | 4421 | 0.180 |
Why?
|
United States | 18 | 2024 | 72238 | 0.170 |
Why?
|
Oxygen Consumption | 1 | 2006 | 1841 | 0.170 |
Why?
|
Child | 14 | 2024 | 79604 | 0.170 |
Why?
|
Trauma Severity Indices | 2 | 2013 | 477 | 0.170 |
Why?
|
Renal Colic | 2 | 2018 | 27 | 0.170 |
Why?
|
Thrombolytic Therapy | 2 | 2006 | 2106 | 0.170 |
Why?
|
Europe | 2 | 2023 | 3427 | 0.170 |
Why?
|
Altitude | 2 | 2013 | 158 | 0.170 |
Why?
|
Hospitals, Community | 1 | 2002 | 367 | 0.160 |
Why?
|
Erythrocyte Transfusion | 1 | 2024 | 564 | 0.160 |
Why?
|
Dogs | 1 | 2024 | 3839 | 0.160 |
Why?
|
Curriculum | 3 | 2016 | 3710 | 0.160 |
Why?
|
Patient Transfer | 2 | 2005 | 775 | 0.160 |
Why?
|
Hyperglycemia | 1 | 2007 | 1376 | 0.160 |
Why?
|
Hypoglycemic Agents | 1 | 2011 | 3153 | 0.160 |
Why?
|
Drug Delivery Systems | 1 | 2010 | 2218 | 0.160 |
Why?
|
Clinical Protocols | 1 | 2024 | 1438 | 0.150 |
Why?
|
Esophagus | 1 | 2024 | 1023 | 0.150 |
Why?
|
Blood Pressure | 2 | 2013 | 8520 | 0.150 |
Why?
|
California | 2 | 2020 | 1403 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 20461 | 0.150 |
Why?
|
Age Factors | 4 | 2024 | 18391 | 0.140 |
Why?
|
Terminology as Topic | 1 | 2024 | 1534 | 0.140 |
Why?
|
Hydronephrosis | 1 | 2018 | 271 | 0.140 |
Why?
|
Databases, Factual | 2 | 2024 | 8001 | 0.140 |
Why?
|
Hospitals | 2 | 2009 | 3929 | 0.130 |
Why?
|
Clinical Competence | 4 | 2018 | 4775 | 0.130 |
Why?
|
Infant | 7 | 2024 | 35940 | 0.130 |
Why?
|
Length of Stay | 2 | 2021 | 6452 | 0.130 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2020 | 10825 | 0.130 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2019 | 498 | 0.130 |
Why?
|
Risk Assessment | 4 | 2019 | 24049 | 0.130 |
Why?
|
Aged, 80 and over | 11 | 2013 | 58864 | 0.130 |
Why?
|
Quality Assurance, Health Care | 2 | 2013 | 2179 | 0.130 |
Why?
|
Manometry | 2 | 2010 | 454 | 0.120 |
Why?
|
Wounds, Nonpenetrating | 1 | 2002 | 795 | 0.120 |
Why?
|
Suicide, Attempted | 1 | 2024 | 1386 | 0.120 |
Why?
|
Headache | 1 | 2003 | 1249 | 0.120 |
Why?
|
Anti-Bacterial Agents | 2 | 2013 | 7379 | 0.120 |
Why?
|
Random Allocation | 2 | 2016 | 2393 | 0.120 |
Why?
|
Education, Medical, Graduate | 2 | 2016 | 2352 | 0.120 |
Why?
|
Sex Distribution | 1 | 2019 | 2294 | 0.120 |
Why?
|
Medical Audit | 2 | 2008 | 451 | 0.120 |
Why?
|
Practice Guidelines as Topic | 3 | 2013 | 7460 | 0.110 |
Why?
|
Ambulances | 2 | 2005 | 92 | 0.110 |
Why?
|
Age Distribution | 1 | 2019 | 2891 | 0.110 |
Why?
|
Boston | 5 | 2008 | 9274 | 0.110 |
Why?
|
Deamino Arginine Vasopressin | 1 | 2013 | 87 | 0.110 |
Why?
|
Fasting | 1 | 2019 | 1603 | 0.110 |
Why?
|
Brain Diseases | 1 | 2002 | 1540 | 0.100 |
Why?
|
Treatment Outcome | 7 | 2024 | 64867 | 0.100 |
Why?
|
Hospitals, Urban | 2 | 2011 | 499 | 0.100 |
Why?
|
Logistic Models | 4 | 2015 | 13309 | 0.100 |
Why?
|
Risk Factors | 6 | 2024 | 74167 | 0.100 |
Why?
|
Arizona | 1 | 2011 | 109 | 0.100 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2012 | 352 | 0.100 |
Why?
|
Prodrugs | 1 | 2013 | 259 | 0.090 |
Why?
|
Administration, Intranasal | 2 | 2016 | 471 | 0.090 |
Why?
|
Sensitivity and Specificity | 5 | 2018 | 14648 | 0.090 |
Why?
|
Diagnostic Tests, Routine | 1 | 2016 | 784 | 0.090 |
Why?
|
Administration, Buccal | 1 | 2010 | 13 | 0.090 |
Why?
|
Consensus | 3 | 2018 | 3091 | 0.090 |
Why?
|
Safety Management | 2 | 2009 | 760 | 0.090 |
Why?
|
Patient Satisfaction | 2 | 2016 | 3448 | 0.090 |
Why?
|
Survival Analysis | 1 | 2023 | 10181 | 0.090 |
Why?
|
Hemostatics | 1 | 2013 | 243 | 0.090 |
Why?
|
Self-Evaluation Programs | 1 | 2009 | 29 | 0.090 |
Why?
|
Feasibility Studies | 2 | 2012 | 5192 | 0.090 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2013 | 380 | 0.090 |
Why?
|
Brain Injuries | 1 | 2002 | 2043 | 0.090 |
Why?
|
Platelet Aggregation | 1 | 2013 | 800 | 0.090 |
Why?
|
Efficiency | 1 | 2013 | 477 | 0.090 |
Why?
|
Learning | 1 | 2019 | 1729 | 0.090 |
Why?
|
Sulfonylurea Compounds | 1 | 2011 | 221 | 0.090 |
Why?
|
Equipment Design | 2 | 2010 | 3529 | 0.080 |
Why?
|
Tracheal Diseases | 1 | 2010 | 115 | 0.080 |
Why?
|
Survival | 1 | 2009 | 161 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2530 | 0.080 |
Why?
|
Point-of-Care Systems | 1 | 2018 | 1208 | 0.080 |
Why?
|
Hospitals, Teaching | 2 | 2011 | 1166 | 0.080 |
Why?
|
Patient Admission | 2 | 2024 | 1383 | 0.080 |
Why?
|
United States Government Agencies | 1 | 2008 | 26 | 0.080 |
Why?
|
Ulcer | 1 | 2010 | 205 | 0.080 |
Why?
|
Pilot Projects | 4 | 2016 | 8530 | 0.080 |
Why?
|
Intermittent Pneumatic Compression Devices | 1 | 2008 | 28 | 0.080 |
Why?
|
Severity of Illness Index | 7 | 2023 | 15815 | 0.080 |
Why?
|
Oxycodone | 1 | 2010 | 138 | 0.080 |
Why?
|
Education, Medical, Undergraduate | 2 | 2009 | 1065 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 2 | 2016 | 8147 | 0.080 |
Why?
|
Students, Medical | 2 | 2019 | 1921 | 0.070 |
Why?
|
Administration, Cutaneous | 1 | 2010 | 711 | 0.070 |
Why?
|
Ticlopidine | 1 | 2013 | 895 | 0.070 |
Why?
|
Forearm Injuries | 1 | 2007 | 68 | 0.070 |
Why?
|
Animals | 5 | 2024 | 167531 | 0.070 |
Why?
|
Pressure | 1 | 2010 | 1155 | 0.070 |
Why?
|
Needles | 1 | 2010 | 452 | 0.070 |
Why?
|
Methicillin Resistance | 1 | 2007 | 199 | 0.070 |
Why?
|
Population Surveillance | 1 | 2017 | 2610 | 0.070 |
Why?
|
Single-Blind Method | 1 | 2010 | 1574 | 0.070 |
Why?
|
Regional Medical Programs | 2 | 2003 | 68 | 0.060 |
Why?
|
Soft Tissue Infections | 1 | 2007 | 168 | 0.060 |
Why?
|
Abducens Nerve Diseases | 1 | 2005 | 44 | 0.060 |
Why?
|
Blood Glucose | 2 | 2011 | 6366 | 0.060 |
Why?
|
Paresis | 1 | 2006 | 176 | 0.060 |
Why?
|
Middle Cerebral Artery | 1 | 2006 | 274 | 0.060 |
Why?
|
Glasgow Coma Scale | 2 | 2009 | 579 | 0.060 |
Why?
|
Plasma | 2 | 2005 | 583 | 0.060 |
Why?
|
Waiting Lists | 1 | 2009 | 749 | 0.060 |
Why?
|
Leadership | 2 | 2004 | 1368 | 0.060 |
Why?
|
Confidence Intervals | 1 | 2010 | 2932 | 0.060 |
Why?
|
Pulmonary Edema | 1 | 2007 | 409 | 0.060 |
Why?
|
Blood Component Transfusion | 1 | 2004 | 141 | 0.060 |
Why?
|
Equipment Safety | 1 | 2005 | 258 | 0.060 |
Why?
|
Patient Readmission | 1 | 2018 | 3323 | 0.060 |
Why?
|
Mountaineering | 1 | 2003 | 45 | 0.050 |
Why?
|
Policy Making | 2 | 2004 | 538 | 0.050 |
Why?
|
Angioedema | 1 | 2004 | 192 | 0.050 |
Why?
|
Rats | 2 | 2016 | 23577 | 0.050 |
Why?
|
Brain Ischemia | 2 | 2007 | 3128 | 0.050 |
Why?
|
Incidence | 3 | 2024 | 21344 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 25853 | 0.050 |
Why?
|
Patient Preference | 1 | 2010 | 919 | 0.050 |
Why?
|
Injections, Intravenous | 2 | 2016 | 1384 | 0.050 |
Why?
|
Pregnancy | 1 | 2024 | 29650 | 0.050 |
Why?
|
Hospitals, Pediatric | 1 | 2011 | 1840 | 0.050 |
Why?
|
Nepal | 1 | 2003 | 301 | 0.050 |
Why?
|
Licensure, Medical | 1 | 2002 | 68 | 0.050 |
Why?
|
Cost-Benefit Analysis | 2 | 2013 | 5499 | 0.050 |
Why?
|
Risk | 1 | 2014 | 9622 | 0.050 |
Why?
|
Consciousness Disorders | 1 | 2006 | 439 | 0.050 |
Why?
|
Radiology | 2 | 2018 | 2104 | 0.050 |
Why?
|
Cause of Death | 1 | 2012 | 3719 | 0.050 |
Why?
|
Diagnosis | 1 | 2002 | 157 | 0.050 |
Why?
|
Informed Consent | 1 | 2007 | 1007 | 0.050 |
Why?
|
Operating Rooms | 1 | 2007 | 785 | 0.050 |
Why?
|
Medical Errors | 1 | 2009 | 1254 | 0.050 |
Why?
|
Peritonitis | 1 | 2003 | 370 | 0.040 |
Why?
|
Insurance Coverage | 1 | 2012 | 1939 | 0.040 |
Why?
|
Survival Rate | 3 | 2017 | 12793 | 0.040 |
Why?
|
Equipment and Supplies | 1 | 2002 | 276 | 0.040 |
Why?
|
Aortic Aneurysm | 1 | 2005 | 646 | 0.040 |
Why?
|
Hospitalization | 2 | 2018 | 10732 | 0.040 |
Why?
|
Insurance, Health | 1 | 2012 | 2500 | 0.040 |
Why?
|
Guidelines as Topic | 2 | 2004 | 1395 | 0.040 |
Why?
|
Intracranial Pressure | 1 | 2002 | 325 | 0.040 |
Why?
|
Diagnosis, Differential | 3 | 2010 | 12963 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6530 | 0.040 |
Why?
|
Documentation | 1 | 2005 | 885 | 0.040 |
Why?
|
Emergency Treatment | 1 | 2002 | 498 | 0.040 |
Why?
|
Withholding Treatment | 1 | 2003 | 612 | 0.040 |
Why?
|
Program Evaluation | 1 | 2007 | 2487 | 0.040 |
Why?
|
Staphylococcal Infections | 1 | 2007 | 1404 | 0.040 |
Why?
|
Acute Disease | 2 | 2006 | 7247 | 0.040 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 7790 | 0.040 |
Why?
|
Health Status Indicators | 1 | 2003 | 968 | 0.040 |
Why?
|
Fractures, Bone | 1 | 2010 | 2035 | 0.040 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2007 | 1199 | 0.040 |
Why?
|
Cohort Studies | 3 | 2006 | 41266 | 0.040 |
Why?
|
Carbon Dioxide | 1 | 2002 | 1144 | 0.040 |
Why?
|
Hemodynamics | 1 | 2007 | 4164 | 0.040 |
Why?
|
Warfarin | 1 | 2005 | 1516 | 0.040 |
Why?
|
Physical Examination | 1 | 2003 | 1243 | 0.030 |
Why?
|
Respiratory Insufficiency | 1 | 2005 | 1225 | 0.030 |
Why?
|
Ketorolac Tromethamine | 1 | 2016 | 21 | 0.030 |
Why?
|
Emergencies | 1 | 2003 | 1217 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 10329 | 0.030 |
Why?
|
Sex Factors | 1 | 2010 | 10515 | 0.030 |
Why?
|
Critical Care | 2 | 2005 | 2692 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2010 | 20027 | 0.030 |
Why?
|
Antidiuretic Agents | 1 | 2013 | 21 | 0.030 |
Why?
|
Bleeding Time | 1 | 2013 | 84 | 0.030 |
Why?
|
Odds Ratio | 2 | 2005 | 9712 | 0.030 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2016 | 370 | 0.030 |
Why?
|
Massachusetts | 1 | 2005 | 8788 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2005 | 12152 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2004 | 3694 | 0.030 |
Why?
|
Regression Analysis | 1 | 2002 | 6358 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2013 | 11891 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 2002 | 2725 | 0.020 |
Why?
|
Calcium | 1 | 2024 | 5718 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2002 | 2617 | 0.020 |
Why?
|
Needs Assessment | 1 | 2016 | 1137 | 0.020 |
Why?
|
Drug Utilization | 1 | 2016 | 1195 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2005 | 4356 | 0.020 |
Why?
|
Online Systems | 1 | 2009 | 181 | 0.020 |
Why?
|
Crowding | 1 | 2009 | 142 | 0.020 |
Why?
|
Self-Assessment | 1 | 2009 | 393 | 0.020 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2007 | 94 | 0.020 |
Why?
|
Clindamycin | 1 | 2007 | 140 | 0.020 |
Why?
|
Seawater | 1 | 2007 | 119 | 0.020 |
Why?
|
Prevalence | 1 | 2024 | 15639 | 0.020 |
Why?
|
Prognosis | 2 | 2007 | 29559 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6490 | 0.020 |
Why?
|
Registries | 1 | 2002 | 8435 | 0.020 |
Why?
|
Hypesthesia | 1 | 2005 | 107 | 0.020 |
Why?
|
Complement C1 Inactivator Proteins | 1 | 2004 | 92 | 0.010 |
Why?
|
Evidence-Based Practice | 1 | 2009 | 492 | 0.010 |
Why?
|
Medication Adherence | 1 | 2016 | 2161 | 0.010 |
Why?
|
Diplopia | 1 | 2005 | 214 | 0.010 |
Why?
|
International Normalized Ratio | 1 | 2005 | 386 | 0.010 |
Why?
|
Health Insurance Portability and Accountability Act | 1 | 2004 | 105 | 0.010 |
Why?
|
Abscess | 1 | 2007 | 604 | 0.010 |
Why?
|
Planning Techniques | 1 | 2003 | 81 | 0.010 |
Why?
|
Clinical Clerkship | 1 | 2009 | 562 | 0.010 |
Why?
|
Community-Acquired Infections | 1 | 2007 | 461 | 0.010 |
Why?
|
Vitamin K | 1 | 2005 | 321 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2005 | 916 | 0.010 |
Why?
|
Teaching | 1 | 2009 | 1161 | 0.010 |
Why?
|
Advisory Committees | 1 | 2006 | 788 | 0.010 |
Why?
|
Pyridines | 1 | 2013 | 2876 | 0.010 |
Why?
|
Societies, Medical | 1 | 2013 | 3890 | 0.010 |
Why?
|
Professional Competence | 1 | 2004 | 431 | 0.010 |
Why?
|
Transplants | 1 | 2003 | 205 | 0.010 |
Why?
|
Organizational Culture | 1 | 2004 | 505 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2005 | 1253 | 0.010 |
Why?
|
Educational Measurement | 1 | 2006 | 1249 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5310 | 0.010 |
Why?
|
Faculty, Medical | 1 | 2006 | 1185 | 0.010 |
Why?
|
Disasters | 1 | 2003 | 511 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2005 | 2062 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18094 | 0.010 |
Why?
|
Multiple Sclerosis | 1 | 2005 | 3190 | 0.010 |
Why?
|
Critical Illness | 1 | 2003 | 2703 | 0.010 |
Why?
|
Disease Progression | 1 | 2005 | 13470 | 0.000 |
Why?
|
Health Services Accessibility | 1 | 2003 | 5366 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2007 | 39213 | 0.000 |
Why?
|